Loading…

Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome

Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming; thus, genetic analysis has thus been introduced and is continually being devel...

Full description

Saved in:
Bibliographic Details
Published in:Balkan medical journal 2018-03, Vol.35 (2), p.163-166
Main Authors: Karaca, Emin, Aykut, Ayça, Ertürk, Biray, Durmaz, Burak, Güler, Ahmet, Büke, Barış, Yeniel, Ahmet Özgür, Ergenoğlu, Ahmet Mete, Özkınay, Ferda, Özeren, Mehmet, Kazandı, Mert, Akercan, Fuat, Sağol, Sermet, Gündüz, Cumhur, Çoğulu, Özgür
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2081-1c1834fb8a0d85aaa7b708080b6e03d0c96318513acfbf060b4f21b29f184e133
cites
container_end_page 166
container_issue 2
container_start_page 163
container_title Balkan medical journal
container_volume 35
creator Karaca, Emin
Aykut, Ayça
Ertürk, Biray
Durmaz, Burak
Güler, Ahmet
Büke, Barış
Yeniel, Ahmet Özgür
Ergenoğlu, Ahmet Mete
Özkınay, Ferda
Özeren, Mehmet
Kazandı, Mert
Akercan, Fuat
Sağol, Sermet
Gündüz, Cumhur
Çoğulu, Özgür
description Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming; thus, genetic analysis has thus been introduced and is continually being developed for rapid prenatal diagnosis. For this reason, the effective use of microRNA profiling for the rapid analysis of prenatal amniotic fluid samples for the diagnosis of Down syndrome was investigated. Aims: To evaluate the expression levels of 14 microRNAs encoded by chromosome 21 in amniotic fluid samples and their utility for prenatal diagnosis of Down syndrome. Study Design: Case-control study. Methods: We performed invasive prenatal testing for 56 pregnant women; 23 carried fetuses with Down syndrome, and 33 carried fetuses with a normal karyotype. Advanced maternal age and increased risk for Down syndrome in the screening tests were indications for invasive prenatal testing. The age of gestation in the study and control groups ranged between 17 and 18 weeks. The expression levels of microRNA were measured by real-time polymerase chain reaction. Results: The expression levels of microRNA-125b-2, microRNA-155, and microRNA-3156 were significantly higher in the study group than in the control group. Conclusion: The presence of significantly dysregulated microRNAs may be associated with either the phenotype or the result of abnormal development. Further large-scale comparative studies conducted in a variety of conditions may bring novel insights in the field of abnormal prenatal conditions.
doi_str_mv 10.4274/balkanmedj.2017.0511
format article
fullrecord <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4456d579588345c4992475c753234e0f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4456d579588345c4992475c753234e0f</doaj_id><sourcerecordid>oai_doaj_org_article_4456d579588345c4992475c753234e0f</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2081-1c1834fb8a0d85aaa7b708080b6e03d0c96318513acfbf060b4f21b29f184e133</originalsourceid><addsrcrecordid>eNpFkclOwzAQhiMEEhX0DTj4BVq8ZjlWLUulsqgFcbQmid26JHZlB5Xy9DgUgefgWexvNPMnyRXBY04zfl1C8w62VfV2TDHJxlgQcpIMKOHpiBFGTv98ys6TYQhbHE-KGWfFIPmaGVhbFzpToaVrFHIaPZjKu-XjBN187rwKwTiLnr3TJpaNRd1GxVBZ6KBBk9Ya13--bT5MjVbQ7hoVekp8srZgO_TmWmXR3nQbNHN7i1YHW_uYu0zONDRBDX_vi-T19uZlej9aPN3Np5PFqKI4JyNSkZxxXeaA61wAQFZmOI9WpgqzGldFykguCINKlzoOVnJNSUkLTXKuCGMXyfzIrR1s5c6bFvxBOjDyJ-H8WoKPIzRKci7SWmSFyGNLUfGioDwTVSYYZVxhHVn8yIobCsEr_ccjWPZyyH85ZC-H7OVg3_Ydf7I</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Karaca, Emin ; Aykut, Ayça ; Ertürk, Biray ; Durmaz, Burak ; Güler, Ahmet ; Büke, Barış ; Yeniel, Ahmet Özgür ; Ergenoğlu, Ahmet Mete ; Özkınay, Ferda ; Özeren, Mehmet ; Kazandı, Mert ; Akercan, Fuat ; Sağol, Sermet ; Gündüz, Cumhur ; Çoğulu, Özgür</creator><creatorcontrib>Karaca, Emin ; Aykut, Ayça ; Ertürk, Biray ; Durmaz, Burak ; Güler, Ahmet ; Büke, Barış ; Yeniel, Ahmet Özgür ; Ergenoğlu, Ahmet Mete ; Özkınay, Ferda ; Özeren, Mehmet ; Kazandı, Mert ; Akercan, Fuat ; Sağol, Sermet ; Gündüz, Cumhur ; Çoğulu, Özgür</creatorcontrib><description>Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming; thus, genetic analysis has thus been introduced and is continually being developed for rapid prenatal diagnosis. For this reason, the effective use of microRNA profiling for the rapid analysis of prenatal amniotic fluid samples for the diagnosis of Down syndrome was investigated. Aims: To evaluate the expression levels of 14 microRNAs encoded by chromosome 21 in amniotic fluid samples and their utility for prenatal diagnosis of Down syndrome. Study Design: Case-control study. Methods: We performed invasive prenatal testing for 56 pregnant women; 23 carried fetuses with Down syndrome, and 33 carried fetuses with a normal karyotype. Advanced maternal age and increased risk for Down syndrome in the screening tests were indications for invasive prenatal testing. The age of gestation in the study and control groups ranged between 17 and 18 weeks. The expression levels of microRNA were measured by real-time polymerase chain reaction. Results: The expression levels of microRNA-125b-2, microRNA-155, and microRNA-3156 were significantly higher in the study group than in the control group. Conclusion: The presence of significantly dysregulated microRNAs may be associated with either the phenotype or the result of abnormal development. Further large-scale comparative studies conducted in a variety of conditions may bring novel insights in the field of abnormal prenatal conditions.</description><identifier>ISSN: 2146-3123</identifier><identifier>EISSN: 2146-3131</identifier><identifier>DOI: 10.4274/balkanmedj.2017.0511</identifier><language>eng</language><publisher>Galenos Publishing House</publisher><subject>amniotic fluid ; Down syndrome ; microRNAs</subject><ispartof>Balkan medical journal, 2018-03, Vol.35 (2), p.163-166</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2081-1c1834fb8a0d85aaa7b708080b6e03d0c96318513acfbf060b4f21b29f184e133</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Karaca, Emin</creatorcontrib><creatorcontrib>Aykut, Ayça</creatorcontrib><creatorcontrib>Ertürk, Biray</creatorcontrib><creatorcontrib>Durmaz, Burak</creatorcontrib><creatorcontrib>Güler, Ahmet</creatorcontrib><creatorcontrib>Büke, Barış</creatorcontrib><creatorcontrib>Yeniel, Ahmet Özgür</creatorcontrib><creatorcontrib>Ergenoğlu, Ahmet Mete</creatorcontrib><creatorcontrib>Özkınay, Ferda</creatorcontrib><creatorcontrib>Özeren, Mehmet</creatorcontrib><creatorcontrib>Kazandı, Mert</creatorcontrib><creatorcontrib>Akercan, Fuat</creatorcontrib><creatorcontrib>Sağol, Sermet</creatorcontrib><creatorcontrib>Gündüz, Cumhur</creatorcontrib><creatorcontrib>Çoğulu, Özgür</creatorcontrib><title>Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome</title><title>Balkan medical journal</title><description>Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming; thus, genetic analysis has thus been introduced and is continually being developed for rapid prenatal diagnosis. For this reason, the effective use of microRNA profiling for the rapid analysis of prenatal amniotic fluid samples for the diagnosis of Down syndrome was investigated. Aims: To evaluate the expression levels of 14 microRNAs encoded by chromosome 21 in amniotic fluid samples and their utility for prenatal diagnosis of Down syndrome. Study Design: Case-control study. Methods: We performed invasive prenatal testing for 56 pregnant women; 23 carried fetuses with Down syndrome, and 33 carried fetuses with a normal karyotype. Advanced maternal age and increased risk for Down syndrome in the screening tests were indications for invasive prenatal testing. The age of gestation in the study and control groups ranged between 17 and 18 weeks. The expression levels of microRNA were measured by real-time polymerase chain reaction. Results: The expression levels of microRNA-125b-2, microRNA-155, and microRNA-3156 were significantly higher in the study group than in the control group. Conclusion: The presence of significantly dysregulated microRNAs may be associated with either the phenotype or the result of abnormal development. Further large-scale comparative studies conducted in a variety of conditions may bring novel insights in the field of abnormal prenatal conditions.</description><subject>amniotic fluid</subject><subject>Down syndrome</subject><subject>microRNAs</subject><issn>2146-3123</issn><issn>2146-3131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpFkclOwzAQhiMEEhX0DTj4BVq8ZjlWLUulsqgFcbQmid26JHZlB5Xy9DgUgefgWexvNPMnyRXBY04zfl1C8w62VfV2TDHJxlgQcpIMKOHpiBFGTv98ys6TYQhbHE-KGWfFIPmaGVhbFzpToaVrFHIaPZjKu-XjBN187rwKwTiLnr3TJpaNRd1GxVBZ6KBBk9Ya13--bT5MjVbQ7hoVekp8srZgO_TmWmXR3nQbNHN7i1YHW_uYu0zONDRBDX_vi-T19uZlej9aPN3Np5PFqKI4JyNSkZxxXeaA61wAQFZmOI9WpgqzGldFykguCINKlzoOVnJNSUkLTXKuCGMXyfzIrR1s5c6bFvxBOjDyJ-H8WoKPIzRKci7SWmSFyGNLUfGioDwTVSYYZVxhHVn8yIobCsEr_ccjWPZyyH85ZC-H7OVg3_Ydf7I</recordid><startdate>20180315</startdate><enddate>20180315</enddate><creator>Karaca, Emin</creator><creator>Aykut, Ayça</creator><creator>Ertürk, Biray</creator><creator>Durmaz, Burak</creator><creator>Güler, Ahmet</creator><creator>Büke, Barış</creator><creator>Yeniel, Ahmet Özgür</creator><creator>Ergenoğlu, Ahmet Mete</creator><creator>Özkınay, Ferda</creator><creator>Özeren, Mehmet</creator><creator>Kazandı, Mert</creator><creator>Akercan, Fuat</creator><creator>Sağol, Sermet</creator><creator>Gündüz, Cumhur</creator><creator>Çoğulu, Özgür</creator><general>Galenos Publishing House</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>20180315</creationdate><title>Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome</title><author>Karaca, Emin ; Aykut, Ayça ; Ertürk, Biray ; Durmaz, Burak ; Güler, Ahmet ; Büke, Barış ; Yeniel, Ahmet Özgür ; Ergenoğlu, Ahmet Mete ; Özkınay, Ferda ; Özeren, Mehmet ; Kazandı, Mert ; Akercan, Fuat ; Sağol, Sermet ; Gündüz, Cumhur ; Çoğulu, Özgür</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2081-1c1834fb8a0d85aaa7b708080b6e03d0c96318513acfbf060b4f21b29f184e133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>amniotic fluid</topic><topic>Down syndrome</topic><topic>microRNAs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karaca, Emin</creatorcontrib><creatorcontrib>Aykut, Ayça</creatorcontrib><creatorcontrib>Ertürk, Biray</creatorcontrib><creatorcontrib>Durmaz, Burak</creatorcontrib><creatorcontrib>Güler, Ahmet</creatorcontrib><creatorcontrib>Büke, Barış</creatorcontrib><creatorcontrib>Yeniel, Ahmet Özgür</creatorcontrib><creatorcontrib>Ergenoğlu, Ahmet Mete</creatorcontrib><creatorcontrib>Özkınay, Ferda</creatorcontrib><creatorcontrib>Özeren, Mehmet</creatorcontrib><creatorcontrib>Kazandı, Mert</creatorcontrib><creatorcontrib>Akercan, Fuat</creatorcontrib><creatorcontrib>Sağol, Sermet</creatorcontrib><creatorcontrib>Gündüz, Cumhur</creatorcontrib><creatorcontrib>Çoğulu, Özgür</creatorcontrib><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Balkan medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karaca, Emin</au><au>Aykut, Ayça</au><au>Ertürk, Biray</au><au>Durmaz, Burak</au><au>Güler, Ahmet</au><au>Büke, Barış</au><au>Yeniel, Ahmet Özgür</au><au>Ergenoğlu, Ahmet Mete</au><au>Özkınay, Ferda</au><au>Özeren, Mehmet</au><au>Kazandı, Mert</au><au>Akercan, Fuat</au><au>Sağol, Sermet</au><au>Gündüz, Cumhur</au><au>Çoğulu, Özgür</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome</atitle><jtitle>Balkan medical journal</jtitle><date>2018-03-15</date><risdate>2018</risdate><volume>35</volume><issue>2</issue><spage>163</spage><epage>166</epage><pages>163-166</pages><issn>2146-3123</issn><eissn>2146-3131</eissn><abstract>Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming; thus, genetic analysis has thus been introduced and is continually being developed for rapid prenatal diagnosis. For this reason, the effective use of microRNA profiling for the rapid analysis of prenatal amniotic fluid samples for the diagnosis of Down syndrome was investigated. Aims: To evaluate the expression levels of 14 microRNAs encoded by chromosome 21 in amniotic fluid samples and their utility for prenatal diagnosis of Down syndrome. Study Design: Case-control study. Methods: We performed invasive prenatal testing for 56 pregnant women; 23 carried fetuses with Down syndrome, and 33 carried fetuses with a normal karyotype. Advanced maternal age and increased risk for Down syndrome in the screening tests were indications for invasive prenatal testing. The age of gestation in the study and control groups ranged between 17 and 18 weeks. The expression levels of microRNA were measured by real-time polymerase chain reaction. Results: The expression levels of microRNA-125b-2, microRNA-155, and microRNA-3156 were significantly higher in the study group than in the control group. Conclusion: The presence of significantly dysregulated microRNAs may be associated with either the phenotype or the result of abnormal development. Further large-scale comparative studies conducted in a variety of conditions may bring novel insights in the field of abnormal prenatal conditions.</abstract><pub>Galenos Publishing House</pub><doi>10.4274/balkanmedj.2017.0511</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2146-3123
ispartof Balkan medical journal, 2018-03, Vol.35 (2), p.163-166
issn 2146-3123
2146-3131
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4456d579588345c4992475c753234e0f
source PubMed Central Free; Publicly Available Content Database
subjects amniotic fluid
Down syndrome
microRNAs
title Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A33%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20Role%20of%20MicroRNA%20Expression%20Profile%20in%20the%20Prenatal%20Amniotic%20Fluid%20Samples%20of%20Pregnant%20Women%20with%20Down%20Syndrome&rft.jtitle=Balkan%20medical%20journal&rft.au=Karaca,%20Emin&rft.date=2018-03-15&rft.volume=35&rft.issue=2&rft.spage=163&rft.epage=166&rft.pages=163-166&rft.issn=2146-3123&rft.eissn=2146-3131&rft_id=info:doi/10.4274/balkanmedj.2017.0511&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_4456d579588345c4992475c753234e0f%3C/doaj_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2081-1c1834fb8a0d85aaa7b708080b6e03d0c96318513acfbf060b4f21b29f184e133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true